Abstract:Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease (CHD). Although a lower methylation level of whole genome has been demonstrated in TOF patients, little is known regarding the DNA methylation changes in specific gene and its associations with TOF development. NOTCH4 is a mediator of the Notch signalling pathway that plays an important role in normal cardiac development. However, the role of epigenetic regulation of theNOTCH4gene in the pathogenesis of TOF remains unclear. Considering theNOTCH4low mutation frequency and reduced expression in the TOF patients, we hypothesized that abnormal DNA methylation change ofNOTCH4gene may influence its expression and responsible for TOF development. In this study, we measured the promoter methylation status ofNOTCH4and was measured and its regulation mechanism was explored, which may be related to TOF disease. Additionally, the promoter methylation statuses ofNOTCH4was measured in order to further understand epigenetic mechanisms that may serve a role in the development of TOF. Immunohistochemical analysis was used to examine NOTCH4 expression in right ventricular outflow tract myocardial tissues in patients with TOF. Compared with healthy controls, patients with TOF displayed significantly reduced in NOTCH4 expression (P=0.0055). Moreover, bisulphite sequencing suggested that the methylation levels of CpG site 2 in theNOTCH4promoter was significantly higher in the patients than in the controls (P=0.0459). NOTCH4 expression was negatively associated with CpG site 2 methylation levels (r=-0.51; P=0.01). ETS1 transcription factor can serve as transcriptional activators by binding to specific DNA sequences of target genes, such asDLL4andNOTCH4, which serves an important role in normal heart development. Dual-luciferase reporter and electrophoretic mobility shift assays indicated that the ETS1 transcription factor could bind to theNOTCH4promoter region. However, binding of ETS1 to theNOTCH4promoter was abrogated by methylation at the putative ETS1 binding sites. These findings suggested that decreased NOTCH4 expression in patients with TOF may be associated with hypermethylation of CpG site 2 in theNOTCH4promoter region, due to impaired binding of ETS1.

Hypermethylation-mediated down-regulation of lncRNA TBX5-AS1:2 in Tetralogy of Fallot inhibits cell proliferation by reducing TBX5 expression.

CpG Site Hypomethylation at ETS1‑binding Region Regulates DLK1 Expression in Chinese Patients with Tetralogy of Fallot.

Mirna-940 Reduction Contributes to Human Tetralogy of Fallot Development.

DNA methylation status of TBX20 in patients with tetralogy of Fallot

Identification of miRNA–mRNA–TFs Regulatory Network and Crucial Pathways Involved in Tetralogy of Fallot

Fgd5-As1 Is A Hub Lncrna Cerna In Hearts With Tetralogy Of Fallot Which Regulates Congenital Heart Disease Genes Transcriptionally And Epigenetically

Methylation Status of CpG Sites in the NOTCH4 Promoter Region Regulates NOTCH4 Expression in Patients with Tetralogy of Fallot.

TBX20 Loss-of-function Mutation Responsible for Familial Tetralogy of Fallot or Sporadic Persistent Truncus Arteriosus.

Association of Promoter Methylation Statuses of Congenital Heart Defect Candidate Genes with Tetralogy of Fallot

DNA Methylation at CpG Island Shore and RXRα Regulate NR2F2 in Heart Tissues of Tetralogy of Fallot Patients.

Elevated methylation of the RXRA promoter region may be responsible for its downregulated expression in the myocardium of patients with TOF

LINE-1 methylation status and its association with tetralogy of fallot in infants

Expression of Cx43-related microRNAs in patients with tetralogy of Fallot

MicroRNA Deregulation in Right Ventricular Outflow Tract Myocardium in Nonsyndromic Tetralogy of Fallot.

Single-Cell RNA Sequencing Reveals Potential for Endothelial-to-Mesenchymal Transition in Tetralogy of Fallot

Abnormalities of hsa-mir-16 and hsa-mir-124 Affect Mitochondrial Function and Fatty Acid Metabolism in Tetralogy of Fallot

Long Noncoding RNA <i>lnc-TSSK2-8</i> Activates Canonical Wnt/-Catenin Signaling Through Small Heat Shock Proteins HSPA6 and CRYAB

HAND1 Loss-of-Function Mutation Causes Tetralogy of Fallot.

Downregulated Nuclear Lncrna NRON Inhibits SHP2/Wnt/β-catenin Signaling and Cardiomyocyte Differentiation During the Development of Tetralogy of Fallot

Gata5 Loss-Of-Function Mutations Underlie Tetralogy Of Fallot

Genetic Variants of ISL1 Gene Promoter Identified from Congenital Tetralogy of Fallot Patients Alter Cellular Function Forming Disease Basis